Insider Transactions in Q2 2023 at X4 Pharmaceuticals, Inc (XFOR)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,641
-3.19%
|
$2,641
$1.89 P/Share
|
|
Jun 30
2023
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
464
-0.31%
|
$464
$1.89 P/Share
|
|
Jun 23
2023
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
857
-0.56%
|
$857
$1.93 P/Share
|
|
Jun 23
2023
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
6,724
-1.22%
|
$6,724
$1.92 P/Share
|
|
Jun 23
2023
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,417
-6.14%
|
$5,417
$1.93 P/Share
|
|
Jun 15
2023
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
857
-0.56%
|
$1,714
$2.23 P/Share
|
|
Jun 15
2023
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
6,724
-1.21%
|
$13,448
$2.23 P/Share
|
|
Jun 15
2023
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,417
-5.78%
|
$10,834
$2.22 P/Share
|
|
Jun 13
2023
|
William Aliski Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+46.55%
|
-
|
|
Jun 13
2023
|
Gary Bridger Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+46.55%
|
-
|
|
Jun 13
2023
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+46.55%
|
-
|
|
Jun 13
2023
|
Francoise De Craecker Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+46.55%
|
-
|
|
Jun 13
2023
|
Michael S Wyzga Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+46.55%
|
-
|
|
Jun 13
2023
|
Alison Frances Lawton Director |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+46.55%
|
-
|
|
May 31
2023
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
6,292
-1.12%
|
$6,292
$1.95 P/Share
|